Total Payments
$1,190
2024 Payments
$38.37
Companies
16
Transactions
22
Medicare Patients
15,315
Medicare Billing
$2.5M
Payment Breakdown by Category
Food & Beverage$1,190 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,190 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $232.54 | 1 | $0 (2021) |
| Travere Therapeutics, Inc. | $225.77 | 2 | $0 (2022) |
| Abbott Laboratories | $128.31 | 1 | $0 (2021) |
| AKEBIA THERAPEUTICS INC | $123.66 | 1 | $0 (2019) |
| Horizon Therapeutics plc | $113.80 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $89.28 | 1 | $0 (2019) |
| Boston Scientific Corporation | $67.10 | 3 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $63.64 | 3 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $28.42 | 2 | $0 (2018) |
| Ironwood Pharmaceuticals, Inc | $24.20 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38.37 | 2 | Boston Scientific Corporation ($25.01) |
| 2023 | $20.72 | 1 | Boston Scientific Corporation ($20.72) |
| 2022 | $375.00 | 5 | Travere Therapeutics, Inc. ($225.77) |
| 2021 | $403.31 | 4 | Aurinia Pharma U.S., Inc. ($232.54) |
| 2019 | $311.00 | 7 | AKEBIA THERAPEUTICS INC ($123.66) |
| 2018 | $41.30 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($28.42) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/01/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/16/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $126.23 | General |
| 11/15/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $113.80 | General |
| Category: KRYSTEXXA | ||||||
| 10/13/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $99.54 | General |
| 09/28/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/08/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 12/13/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $128.31 | General |
| Category: Heart Failure | ||||||
| 10/21/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $21.75 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 09/09/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $232.54 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/16/2021 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $20.71 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 12/03/2019 | CSL Behring | Kcentra (Biological) | Food and Beverage | Cash or cash equivalent | $20.94 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 07/21/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $123.66 | General |
| Category: NEPHROLOGY | ||||||
| 05/01/2019 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 04/17/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/05/2019 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), Linzess | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Gastroenterology | ||||||
| 03/26/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $89.28 | General |
| Category: NEPHROLOGY | ||||||
| 02/07/2019 | Shionogi Inc | Mulpleta (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 07/09/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/15/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Virology | ||||||
| 05/09/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 4,090 | 12,204 | $2.0M | $728,011 |
| 2022 | 4 | 3,850 | 10,630 | $1.7M | $618,578 |
| 2021 | 5 | 3,676 | 9,565 | $1.6M | $569,175 |
| 2020 | 8 | 3,699 | 9,536 | $1.9M | $567,052 |
Total Patients
15,315
Total Services
41,935
Medicare Billing
$2.5M
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 2,085 | 6,987 | $1.2M | $354,106 | 29.8% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 1,067 | 3,101 | $403,200 | $196,484 | 48.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 881 | 2,009 | $351,575 | $174,657 | 49.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 45 | 80 | $10,600 | $2,170 | 20.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 12 | 27 | $742.50 | $593.99 | 80.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 2,027 | 6,365 | $1.1M | $312,966 | 28.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 834 | 1,898 | $332,150 | $161,906 | 48.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 967 | 2,327 | $307,230 | $142,421 | 46.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 22 | 40 | $9,839 | $1,285 | 13.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 1,942 | 6,182 | $1.1M | $318,785 | 30.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 797 | 1,774 | $330,443 | $153,541 | 46.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2021 | 889 | 1,530 | $213,087 | $94,924 | 44.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 35 | 51 | $8,230 | $1,344 | 16.3% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2021 | 13 | 28 | $742.50 | $580.94 | 78.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 1,875 | 6,168 | $1.1M | $326,604 | 30.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2020 | 791 | 1,866 | $464,634 | $153,786 | 33.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2020 | 861 | 1,287 | $241,838 | $74,593 | 30.8% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2020 | 16 | 16 | $25,600 | $4,226 | 16.5% |
| 88112 | Cell examination of specimen | Office | 2020 | 92 | 94 | $27,772 | $3,926 | 14.1% |
| 88342 | Tissue or cell analysis by immunologic technique | Office | 2020 | 37 | 57 | $12,083 | $2,556 | 21.2% |
| 88341 | Special stained specimen slides to examine tissue | Office | 2020 | 15 | 36 | $5,903 | $960.59 | 16.3% |
| 88121 | Cell examination of urine | Office | 2020 | 12 | 12 | $1,796 | $400.44 | 22.3% |
About Dr. Shveta Mehra, MD
Dr. Shveta Mehra, MD is a Anatomic Pathology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962437475.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shveta Mehra, MD has received a total of $1,190 in payments from pharmaceutical and medical device companies, with $38.37 received in 2024. These payments were reported across 22 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,190).
As a Medicare-enrolled provider, Mehra has provided services to 15,315 Medicare beneficiaries, totaling 41,935 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology
- Location Phoenix, AZ
- Active Since 07/12/2006
- Last Updated 11/22/2019
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962437475
Products in Payments
- LUPKYNIS (Drug) $232.54
- CardioMEMS HF System (Device) $128.31
- AURYXIA (Drug) $123.66
- KRYSTEXXA (Biological) $113.80
- JYNARQUE (Drug) $89.28
- Prolaris (Device) $63.64
- UCERIS (Drug) $28.42
- Linzess (Drug) $24.20
- GENERAL PAIN MANAGEMENT (Device) $21.37
- Kcentra (Biological) $20.94
- NASCOBAL (Drug) $15.93
- Mulpleta (Drug) $15.62
- DIFICID (Drug) $14.25
- SUCRAID (Drug) $13.36
- Mavyret (Drug) $12.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Phoenix
Dr. Ronald Paler, Md, MD
Anatomic Pathology — Payments: $27,968
Anatomic Pathology $27,968
Dr. David Greenspan, Md, MD
Anatomic Pathology — Payments: $3,590
Anatomic Pathology $3,590
Dr. Kirk Lin, Md, MD
Anatomic Pathology — Payments: $1,864
Anatomic Pathology $1,864
Qing Cao, Md, MD
Anatomic Pathology — Payments: $122.81
Anatomic Pathology $122.81
Alex Heimbigner, M.d, M.D
Anatomic Pathology — Payments: $98.89
Anatomic Pathology $98.89
Shobhana Shah, M.d, M.D
Anatomic Pathology — Payments: $77.25
Anatomic Pathology $77.25